Close
The following trials are currently running for muscle channel patients:
Bumetanide in Hypokalaemic Periodic Paralysis.
This trial evaluates the safety of Bumetanide in stopping attacks of paralysis. The results of this study will be used to determine if a second larger study should be performed that will evaluate the successfulness of the drug.
All patients who attend clinic are also asked to participate in a study titled:
Investigation of human neurological ion channel disorder.
This study aims to collect detailed information regarding clinical, MRI, neurophysiology and genetic features of muscle channelopathies.
This information is used to help us identify factors that may affect the severity and outcomes in channelopathies and direct our research to new treatments.
We believe that by identifying the mechanisms involved this will help us to develop new therapeutic or preventative strategies for the future. Please contact us if you would like to be involved.